Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Ann Otol Rhinol Laryngol ; 122(11): 665-71, 2013 Nov.
Article in English | MEDLINE | ID: mdl-24358625

ABSTRACT

OBJECTIVES: This study evaluated in-office balloon dilation of maxillary sinus ostia and ethmoid infundibula to treat chronic rhinosinusitis (CRS) and recurrent acute rhinosinusitis (RARS). METHODS: Seventy-four patients with disease in the maxillary and anterior ethmoid sinuses on computed tomography were prospectively enrolled across 12 study centers. All procedures were performed in the office. The primary outcomes were clinical effectiveness and health-care utilization at 1 year, measured by the validated surveys Sino-Nasal Outcome Test (SNOT-20) and Rhinosinusitis Symptom Inventory (RSI). RESULTS: Dilation was successful in 69 patients (93.2%), and the average periprocedural pain level was 3.2 (scale of 0 to 10). The mean improvement on the SNOT-20 at 1 year was clinically and statistically significant (p < 0.0001), with no significant difference between the CRS and RARS patient outcomes. The treatment effect was the same in the CRS and RARS subgroups and was either "moderate" or "large" for 10 of 12 symptoms. The mean numbers of antibiotic courses (p < or = 0.001), sinus-related physician visits (p < 0.0001), and number of acute sinus infections (p < 0.001) decreased significantly in both subgroups. There were no serious device-related adverse events, and the rate of revision surgery was 5.8%. CONCLUSIONS: Stand-alone balloon dilation of the maxillary sinus ostia and ethmoid infundibula performed in the office is well tolerated and effectively treats both CRS and RARS.


Subject(s)
Ambulatory Surgical Procedures/methods , Catheterization/methods , Dilatation/methods , Ethmoid Sinus/surgery , Maxillary Sinus/surgery , Rhinitis/surgery , Sinusitis/surgery , Acute Disease , Adult , Chronic Disease , Ethmoid Sinus/diagnostic imaging , Female , Follow-Up Studies , Humans , Male , Maxillary Sinus/diagnostic imaging , Middle Aged , Prospective Studies , Recurrence , Rhinitis/complications , Rhinitis/diagnostic imaging , Sinusitis/complications , Sinusitis/diagnostic imaging , Time Factors , Tomography, X-Ray Computed , Treatment Outcome
2.
Ear Nose Throat J ; 83(8): 572, 574, 576-8, 2004 Aug.
Article in English | MEDLINE | ID: mdl-15487639

ABSTRACT

Innovative new techniques to resect tonsillar tissue have been described in the recent literature. We report the case of a patient who underwent volume reduction of tonsillar tissue by radiofrequency energy under local anesthesia in an office setting. Treatment resulted in a reduction of tonsillar size with minimal pain, which can be attributed to the avoidance of mucosal interruption. The patient subsequently underwent standard tonsillectomy, which allowed us to examine the histopathology of the tissue that was treated with radiofrequency. In doing so, we noted an absence of fibrosis and preservation of normal histologic architecture. We conclude that performing volume reduction of tonsillar tissue by applying radiofrequency energy to the stroma of the tonsils without temperature control results in objective improvement in airway size with minimal effects on the histopathology of the tonsillar stroma. Mucosa-sparing tonsillar reduction may be a preferable alternative to other techniques of tonsillar reduction, especially for young children, who would experience a nearly pain-free procedure.


Subject(s)
Catheter Ablation/methods , Palatine Tonsil/pathology , Palatine Tonsil/surgery , Adolescent , Catheter Ablation/instrumentation , Female , Humans , Tonsillectomy/adverse effects , Tonsillectomy/instrumentation , Tonsillectomy/methods , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...